Drug intelligence / Profile preview

68Ga-NOTA-MW70

Development stage
Unknown
Lead developer
Huashan Hospital
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration
Intravenous
01

Overview

68Ga-NOTA-MW70 is a radiopharmaceutical diagnostic imaging agent developed by Huashan Hospital, Fudan University, for the detection and characterization of malignant renal tumors, specifically renal cell carcinoma (RCC). The agent consists of the positron-emitting radioisotope Gallium-68 (68Ga) chelated by 1,4,7-triazacyclononane-1,4,7-triacetic acid (NOTA) and conjugated to MW70, a targeting moiety specific for CD70 (Cluster of Differentiation 70). CD70 is a member of the tumor necrosis factor (TNF) superfamily that is highly expressed in various malignancies, including clear cell renal cell carcinoma (ccRCC), while having limited expression in normal tissues. By binding to CD70, 68Ga-NOTA-MW70 allows for non-invasive PET/CT imaging to evaluate quantitative uptake metrics and diagnostic performance, potentially aiding in the staging and management of renal cancer.

Other names
[68Ga]Ga-NOTA-MW7068Ga-labeled NOTA-MW70
02

Targets

CD70 (Cluster of Differentiation 70)

Beyond the preview

Go deeper on 68Ga-NOTA-MW70.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 68Ga-NOTA-MW70.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call